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CASE PRESENTATION
An 18-year-old white male presented to his primary care
doctor with recent onset of headaches. The patient was
found to have a blood pressure of 170/102 mm Hg.
Urinalysis was significant for 4300 mg/dl of protein and
26–50 red cells/high power field. Laboratory evaluation
revealed a serum creatinine 2.2 mg/dl. He was given
metoprolol 50 mg/day and referred for nephrologic
evaluation.
The patient had no history of renal disease, urinary
tract infections, recent sore throat, gross hematuria,
arthralgias, or cutaneous manifestations. He was not
taking any medications. He reported a 2–3 week history of
headaches, intermittent edema, and fatigue. Past medical
history was significant for a staphylococcus infection in
infancy, which was treated with gentamicin. He had mild
auditory impairment that had been attributed to
gentamicin ototoxicity. There was no family history of
renal disease.
At the time of nephrologic evaluation, physical
examination revealed a blood pressure of 170/120 mm Hg
and 1þ lower extremity edema. Fundoscopic
examination revealed dot hemorrhages and exudates in
the left eye. Urinalysis was significant for a specific gravity
of 1.015, a protein concentration 4300 mg/dl, 6–10 white
blood cells/high power field, 20–50 red blood cells/high
power field, and the absence of cellular casts. The urine
protein to creatinine ratio was 8.467.
Laboratory evaluation revealed a blood urea nitrogen
of 23 mg/dl, creatinine 2.2 mg/dl, hematocrit 34.9%,
platelet count 274 000, albumin 1.9 g/dl, and cholesterol
315 mg/dl. The patient had normal liver function tests,
normal C3 and C4 complement levels, and an erythrocyte
sedimentation rate of 37 mm/h. The following serologies
were negative: hepatitis B surface antigen, hepatitis C
antibody, anti-nuclear antibody, anti-neutrophil
cytoplasmic antibody, and anti-streptolysin O. Blood
pressure was controlled with amlodipine 10 mg/day and
valsartan 320 mg/day. Renal biopsy was performed.
RENAL BIOPSY FINDINGS
The sampling for light microscopy included 16 glomeruli,
seven of which were globally sclerotic. Glomeruli appeared
normal in size and ranged from normocellular to mildly
hypercellular owing to an increase in mesangial cells. Multiple
glomeruli exhibited segmental narrow duplication of the
glomerular basement membranes (GBM) (Figure 1a). Seven
glomeruli displayed segmental scars with GBM wrinkling,
increased matrix material, hyaline insudation, and adhesions
to Bowman’s capsule. Proximal tubules contained protein
and lipid resorption droplets, mild degenerative changes, and
focal intraluminal cholesterol clefts. There was moderate to
severe tubular atrophy and interstitial fibrosis involving 60%
of the cortex sampled, with mild interstitial inflammation
and focal interstitial foam cells. Vessels exhibited mild to
moderate arteriolosclerosis with hyalinosis.
Sampling for immunofluorescence consisted of five
glomeruli. Four of the five glomeruli displayed low-intensity
segmental to global tuft staining for C3 (1þ ), IgM (þ /),
kappa (þ /), and lambda (þ /). No discrete granular
positivity was noted. Staining for immunoglobulin G,
immunoglobulin A, and C1q was negative.
Diagnostic findings were seen on ultrastructural
evaluation. There was global thickening and lamellation
of the GBM, imparting a ‘basket-weave’ appearance
(Figure 1b). Segmental GBM thinning was also identified,
with thinned areas exhibiting a mean diameter of 240 nm.
Visceral epithelial cells exhibited 90% foot process efface-
ment. Scattered electron densities were seen within the
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expanded, lamellated GBM, which likely represented
entrapped hyaline. No definitive electron-dense deposits
were apparent.
Immunofluorescence staining for the a1, a3, and a5 chains
of type IV collagen was performed using antibodies obtained
from Wieslab (Lund, Sweden). Staining for the a1 chain of
type IV collagen revealed diffuse positivity (3þ ) in the
mesangium, GBMs, and tubular basement membranes
(TBMs) (Figure 1c). Staining for the a3 chain was entirely
negative. Staining for the a5 chain was positive (3þ ) in
Bowman’s capsule and distal TBMs, but negative in GBMs
(Figure 1d).
PATHOLOGIC DIAGNOSIS
Hereditary nephritis (Alport syndrome), autosomal type
Sampling for light microscopy revealed a focal segmental and
global sclerosing glomerulopathy. Ultrastructural evaluation
revealed diagnostic findings of hereditary nephritis (HN),
including GBM thickening and lamellation, with a ‘basket-
weave’ appearance, alternating with thinned segments.
Immunofluorescence staining for the a1, a3, and a5 chains
of type IV collagen was particularly helpful. There was
complete loss of staining for both the a3 and a5 chains of
type IV collagen in GBMs, confirming the diagnosis of HN.
Staining for the a5 chain of type IV collagen was preserved in
distal TBMs and Bowman’s capsule, indicating an autosomal
pattern of inheritance (Table 1).
Upon further questioning, the absence of a family history
of renal disease was confirmed. Shortly after the biopsy, the
patient was lost to follow-up.
DISCUSSION
HN is an inherited condition characterized by hematuria and
progressive renal insufficiency resulting from genetic defects
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dc
Figure 1 | (a) A glomerulus with segmental narrow duplication of the GBM (arrows) and a segmental adhesion to Bowman’s capsule (periodic
acid Schiff, original magnification  600). (b) Ultrastructural evaluation reveals thickening and lamellation of the GBM, imparting a
‘basket-weave’ appearance (original magnification  6000). (c) Staining for the a1 chain of type IV collagen reveals high intensity positivity in
GBMs, the mesangial matrix, TBMs, and Bowman’s capsule (original magnification  400). (d) Staining for the a5 chain of type IV collagen
reveals high-intensity positivity in Bowman’s capsule and distal TBMs. No significant positivity is seen in the GBM (original magnification
 200).
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in type IV collagen, a major structural component of the
GBM. HN is a rare and phenotypically diverse condition,
with a prevalence of approximately 1 in 50 000.1 In 1927,
Alport described a progressive familial nephropathy asso-
ciated with deafness and disproportionately affecting males.2
As a result of this description, HN is commonly referred to as
Alport syndrome. Approximately half of patients with HN
exhibit extra-renal manifestations, the most common of
which are sensorineural hearing loss and ocular abnormali-
ties, including anterior lenticonus. When extra-renal
manifestations are present, the term Alport syndrome is
referred. The term HN is often used to refer to the isolated
renal disease.
An early, critical step in understanding the genetic basis of
HN was the observation that unlike normal control tissue,
glomeruli from patients with HN often fail to stain with sera
from patients with anti-GBM disease.3 This is because
patients with anti-GBM disease have antibodies directed
against the a3 chain of type IV collagen.
Type IV collagen is composed of six chains, designated
a1–a6. The COL4A1 and COL4A2 genes are located on
chromosome 13, the COL4A3 and COL4A4 on chromosome
2, and COL4A5 and COL4A6 on the X-chromosome. The six
chains assemble into triple-helical protomers, of which only
three configurations are known to occur, a1.a1.a2(IV),
a3.a4.a5.(IV), and a5.a5.a6.(IV).4 The triple helical proto-
mers in turn form hexamers for which only three known
pairings exist: a1.a1.a2.(IV)–a1.a1.a2.(IV), a3.a4.a5.
(IV)–a3.a4.a5.(IV), and a1.a1.a2.(IV)–a5.a5.a6.(IV). The
a1.a1.a2.(IV)–a1.a1.a2.(IV) network is expressed in all renal
basement membranes, including the GBM, Bowman’s
capsule, TBM, and the mesangial matrix. The a3.a4.a5.
(IV)–a3.a4.a5.(IV) network comprises the predominant type
IV collagen in the mature GBM, and is also present in distal
TBMs. Therefore, it is not surprising that mutations
associated with HN uniformly target the COL4A3, COL4A4,
and COL4A5 genes. The a1.a1.a2.(IV)–a5.a5.a6.(IV) network
is expressed in Bowman’s capsule and distal TBMs.
There are three modes of transmission of HN. Approxi-
mately 80% of cases have an X-linked disease, with mutations
involving the COL4A5 gene.5 Autosomal-recessive and
-dominant inheritance are estimated to underlie 15 and 5%
of cases of HN, respectively, and may involve either the
COL4A3 or COL4A4 genes. In cases with autosomal-recessive
inheritance, there is often no known family history of renal
disease as seen in the case reported herein.
The natural history of HN has been well characterized.5
During childhood and early adolescence, the main clinical
manifestation is hematuria. At a later stage, patients develop
proteinuria, which is subsequently followed by progressive
renal failure, ultimately leading to end-stage renal disease
(ESRD). The mean age at which males with X-linked HN
reach ESRD is 25 years.6 The type of mutation in the
COL4A5 gene largely determines the clinical course of
X-linked HN.6 Larger mutations, including deletions, non-
sense mutations, and frame-shift mutations, are associated
with a 90% probability of ESRD by the age of 30 years.6 In
contrast, a slower rate of progression and later onset of ESRD
is seen in patients with missense or splice site mutations, in
which partially functional type IV collagen is synthesized.
Whereas autosomal forms of HN are similarly common in
males and females, it is important to note that X-linked HN
can be seen in females, where it results from skewed
lyonization. Among females with X-linked HN, clinical disease
is less severe, with a probability of developing ESRD of 12% by
the age of 40.7 Interestingly, hearing loss is associated with an
increased risk of ESRD in females with X-linked HN.7
Genetic screening for mutations that cause HN is
extremely difficult because over 200 distinct disease-causing
mutations have been identified.5 As a result, staining for
collagen IV subtypes has become a useful adjunct to establish
a diagnosis of HN. Monoclonal antibodies specific for the a1,
a3, and a5 chains of type IV collagen are commercially
available from Wieslab (Lund, Sweden). Based on the normal
distribution of the collagen IV hexamers, a1 expression is
seen in all basement membranes of the kidney, including the
GBM, Bowman’s capsule, and TBM. This normal staining
pattern for a1 is seen in all cases and serves as a positive
control; no phenotype with loss of a1 has been described.
Expression of a3 is normally seen in GBMs and distal TBMs.
Expression of a5 is identical to a3, but for the additional
finding of positivity in Bowman’s capsule, where the
Table 1 | Renal and cutaneous expression patterns of a subunits of type IV collagen
Alpha-1 in
kidney
Alpha-3 in
kidney
Alpha-5 in
kidney
Alpha-1
in skin
Alpha-3
in skin
Alpha-5
in skin
Normal and Thin basement membrane All renal GBM GBM EBM Absent EBM
nephropathy BMs D-TBM D-TBM
BC
X-linked Alport syndrome (male) All renal Neg Neg EBM Absent Neg
BMs
X-linked Alport syndrome (female) All renal Mosaica Mosaica EBM Absent Mosaica
BMs
Autosomal recessive Alport All renal Neg D-TBM EBM Absent EBM
syndrome BMs BC
BC, Bowman’s capsule; BM, basement membrane; D-TBM, distal tubular BM; EBM, epidermal BM; GBM, glomerular BM.
aMosaic pattern: segmental areas with loss of positivity.
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a1.a1.a2.(IV)–a5.a5.a6.(IV) hexamer is present. Staining
for the a1 and a5 chains of type IV collagen can also
be performed on skin, where both the a1.a1.a2.
(IV)–a1.a1.a2.(IV) and a1.a1.a2.(IV)–a5.a5.a6.(IV) hexam-
ers are expressed in the epidermal basement membrane.
In patients with HN, loss of immunohistochemical
staining for the a3 and a5 chains of type IV collagen is
commonly encountered. In X-linked HN, the loss of a5
expression is typically accompanied by loss of a3, and
includes loss of expression of a5 in Bowman’s capsule. The
loss of expression of a3 and a5 suggests that the patient is
more likely to have a large deletion, nonsense mutation, or
frame-shift mutation, leading to complete absence of the
a3.a4.a5 protomer from the GBM. In contrast, patients with
HN with preserved expression of the a3 and a5 chains are
more likely to have relatively small missense or splice site
mutations that do not disrupt the epitope to which the
commercially available monoclonal antibody is directed.
Thus, loss of expression of a3 and a5 helps to confirm the
diagnosis of HN and suggests that a larger mutation is
present, portending a worse prognosis. Intact staining for a3
and a5 is not diagnostically helpful, but in the setting of
clearcut ultrastructural findings of HN, this finding suggests
that the patient has only a small mutation and is more likely
to have a slower course to renal failure. In contrast to males,
females with X-linked HN more commonly exhibit irregular,
discontinuous loss than complete loss of staining for the a3
and a5 chains, owing to random X-inactivation.
Previous studies suggest that loss of staining for the a3
and a5 chains of type IV collagen occurs in the majority of
patients with HN. Nakanishi et al.8 examined a3 and a5
staining in 16 kindred with ‘basket-weave’ changes of the
GBM and progressive renal failure, eight of which also had
familial deafness. Affected individuals exhibited loss of a5,
with or without loss of a3, in 13 of the 16 kindreds. Naito
et al.9 stained renal biopsies from nine patients with X-linked
HN and found a loss of staining for a3 and a5 in four
patients, including one of six patients with a COL4A5
missense mutation, both patients with a deletion in COL4A5,
and a single patient with a splice site mutation. Gubler et al.10
examined renal biopsies from 12 patients from 11 kindreds
with autosomal-recessive HN and found a loss of a3 and a5
positivity in GBM’s in 11 of 12 patients, with preserved
staining of Bowman’s capsule for a5, similar to that seen in
the case reported herein. Barsotti et al.11 studied 32 cases of
biopsy-proven HN and found loss of staining for a3 and a5
in 17 biopsies; an additional seven biopsies showed loss of
staining for a5, but preserved staining for a3. Taken together,
abnormal staining for a5 was seen in 24 of 32 cases (75%).
Interestingly, subsequent studies have shown that the loss of
a3 and a4 in HN is likely the result of failure of incorporation
into the GBM or early degradation, because COL4A3 and
COL4A4 mRNA are present at levels similar to those of
normal controls.12,13
We reviewed our experience with staining for collagen IV
subtypes in patients for whom the diagnosis of HN could be
clearly established by the clinical, light microscopic, and
electron microscopic findings. We stained 16 cases of biopsy-
proven HN for subtypes of type IV collagen and found a
normal distribution of a1, a3, and a5 in 10 of the 16 cases
(62.5%). Five cases exhibited a loss of a5 in GBMs and
Bowman’s capsule, accompanied by diminished or absent a3
in GBMs, confirming the diagnoses of X-linked HN. The
single case reported herein showed an abnormal phenotype
diagnostic of autosomal HN. In attempting to determine the
prognostic significance of loss of staining for a3 and a5, we
briefly compared some clinical features of cases with intact
staining vs cases with loss of staining. No significant
differences were seen between the two groups with respect
to proteinuria or renal insufficiency. In contrast, patients
with loss of staining for a5 and a3 came to clinical attention
and underwent renal biopsy at a significantly younger age
(16.3 vs 36.6 years; P¼ 0.03). This earlier presentation
supports the hypothesis that loss of staining for a5 and a3,
which typically is the result of a large deletion, nonsense
mutation, or frame-shift mutation, portends a worse
prognosis. Interestingly, we have also stained 10 skin biopsies
for the a1 and a5 chains of type IV collagen, including three
and four individuals, respectively, from two separate
kindreds. In nine of 10 cases, loss of or discontinuous
staining for a5 was identified in the epidermal basement
membrane, supporting the diagnosis of HN.
In the case reported herein, staining for collagen IV
subtypes revealed complete loss of both a3 and a5 from the
GBM, with preserved expression of a5 in Bowman’s capsule
and distal TBMs. Preserved expression of a5 at these two sites
indicates that there is intact expression of the a1.a1.a2.
(IV)–a5.a5.a6.(IV) hexamer. Thus, it is reasonable to
conclude that the patient’s disease-causing mutation is
present in either the COL4A3 or COL4A4 gene. This
observation, along with the absence of a family history of
renal disease, establishes an autosomal pattern of inheritance,
likely autosomal recessive. The loss of a3 and a5 within the
GBM, as well as the history of significant renal insufficiency
and glomerulosclerosis at the age of only 18 years, portends a
poor prognosis. Staining for subtypes of type IV collagen in
renal or skin biopsies is a useful ancillary test to establish the
diagnosis of HN. Loss of staining for a3 and a5 appears to
carry a poor prognosis, although additional studies are
needed to confirm this conclusion.
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